We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Newell Brands
NWL
$2.56B
| $6.15K | ﹤0.01% |
707
+489
| +224% | +$4.86K |
|
1702
Relmada Therapeutics
RLMD
$527M
| $6.15K | ﹤0.01% |
2,500
| – | – |
|
1703
Booz Allen Hamilton
BAH
$9.15B
| $6.14K | ﹤0.01% |
55
-46
| -46% | -$4.55K |
|
1704
WisdomTree Japan SmallCap Dividend Fund
DFJ
$400M
| $6.13K | ﹤0.01% |
92
-258
| -74% | -$17.2K |
|
1705
Alkami Technology
ALKT
$2.11B
| $6.06K | ﹤0.01% |
370
+202
| +120% | +$2.79K |
|
1706
Select Water Solutions
WTTR
$2.61B
| $6.04K | ﹤0.01% |
746
+38
| +5% | +$287 |
|
|
DENN
1707
DELISTED
Denny's
DENN
| $6.04K | ﹤0.01% |
490
| – | – |
|
1708
MiMedx Group
MDXG
$633M
| $6.02K | ﹤0.01% |
911
| – | – |
|
1709
Lifestance Health
LFST
$4.14B
| $6.02K | ﹤0.01% |
659
| – | – |
|
1710
Modine Manufacturing
MOD
$10.4B
| $6.01K | ﹤0.01% |
182
| – | – |
|
1711
ACV Auctions
ACVA
$1.3B
| $5.97K | ﹤0.01% |
346
-19
| -5% | -$290 |
|
1712
RenaissanceRe
RNR
$13.4B
| $5.97K | ﹤0.01% |
32
-2
| -6% | -$398 |
|
1713
Arlo Technologies
ARLO
$1.65B
| $5.97K | ﹤0.01% |
547
| – | – |
|
1714
Reynolds Consumer Products
REYN
$5.59B
| $5.96K | ﹤0.01% |
211
-109
| -34% | -$3.03K |
|
1715
Chemed
CHE
$7.22B
| $5.96K | ﹤0.01% |
11
+1
| +10% | +$547 |
|
1716
Endava
DAVA
$156M
| $5.96K | ﹤0.01% |
115
-100
| -47% | -$5.38K |
|
1717
Marcus & Millichap
MMI
$1.19B
| $5.96K | ﹤0.01% |
189
+8
| +4% | +$247 |
|
1718
Ingles Markets
IMKTA
$1.67B
| $5.95K | ﹤0.01% |
72
| – | – |
|
|
JKS
1719
JinkoSolar
JKS
$891M
| $5.95K | ﹤0.01% |
134
| – | – |
|
1720
AngioDynamics
ANGO
$649M
| $5.93K | ﹤0.01% |
569
+516
| +974% | +$4.97K |
|
|
AHRT
1721
AH Realty Trust
AHRT
$517M
| $5.91K | ﹤0.01% |
506
| – | – |
|
1722
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
| $5.91K | ﹤0.01% |
+152
| New | +$5.65K |
|
1723
Mercury Insurance
MCY
$6.07B
| $5.9K | ﹤0.01% |
195
+82
| +73% | +$2.5K |
|
1724
Adient
ADNT
$1.5B
| $5.9K | ﹤0.01% |
154
+12
| +8% | +$444 |
|
1725
V2X
VVX
$2.65B
| $5.9K | ﹤0.01% |
119
+7
| +6% | +$305 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.